Ahmad Aswad
Critical Care Medicine · Miami, FLNPI 1194956987
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,529 of the $3,084 with a category attached, or 82.0%. Astrazeneca UK Limited accounts for 62.5% of it on its own, with 2 other manufacturers making up the rest.
Across 18 payments — averaging $171.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astrazeneca UK Limited$2K
- Eisai Inc.$1K
- Alkermes, Inc.$21
Across 2,226 payments — averaging $2945.15 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alnylam Pharmaceuticals Inc.$4.2M
- Akebia Therapeutics Inc$2.4M
What the payments were for
- Travel & lodging$2,52982%
- Food & beverage$55618%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astrazeneca UK Limited | 8 | $1,927 |
| Eisai Inc. | 9 | $1,136 |
| Alkermes, Inc. | 1 | $21 |
How this compares
$3,084 in reported general payments places this provider in the 85th percentile of 618 critical care medicine providers in Florida.
Other critical care medicine in Miami
- Michael CamposMiami$70K
- Alexandre AbreuMiami$34K
- Daniel KettMiami$14K
- Louis GuzziOrlando$635K
- Fortune AlabiKissimmee$587K
- Debabrata BandyopadhyayTampa$398K
- Fred UmehKissimmee$371K
- Amit TandonWesley Chapel$338K
- Omid ZadOrlando$325K
- Eddy GutierrezJacksonville$315K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.